The long-term effects of the biolicit procedure for original and biosimilar GCSF and EPO products in Hungary

Aim: We aimed to analyse the long-term effects of the biosimilar bids of NEAK regarding GCSF and EPO drugs. Data and Methods: Our analysis is based on the data derived from the nationwide pharmaceutical database of NEAK. The treatment days and reimbursement figures of 12 months periods has been compared, from 01.07.2011-30.06.2014. and 01.07.2017.-30.06.2019. Results: In the 12 months preceding the price competition bid of biosimilar products 13974 patients received G-CSF, 7.49 billion HUF health insurance reimbursement has been paid, 5 years later the turnover of the product increased (314760, 340100 DOT value), whereas the reimbursement decreased (2.03 billion HUF, 1.95 billion HUF respectively). 12 months before the biosimial price competition, 4167 patients were treated with erythropoietin, resulting in 2.33 billion HUF of reimbursements, in the last 2 years the turnover increased (48727, 50813 DOT value respectively) with decreased reimbursement (1.004 billion HUF, 1.002 billion HUF respectively). Conclusions: The long-range analyses price competition bid of biosimilar products revealed that in case of products the health insurance reimbursement decreased despite the elevated turnover in a longer period as well. During the years following the start of the price competition bid the switch from original products to biosimilars could be observed.

Download Full-text

Anthropogenic Effects on Forest Ecosystems at Various Spatio-Temporal Scales

The Scientific World JOURNAL ◽

10.1100/tsw.2002.129 ◽

2002 ◽

Vol 2 ◽

pp. 827-841 ◽

Cited By ~ 1

Author(s):

Michael Bredemeier

Keyword(s):

Air Pollution ◽

Long Range ◽

Acid Deposition ◽

Soil Degradation ◽

Forest Ecosystems ◽

Global Scale ◽

Soil Productivity ◽

Long Term Effects ◽

The World

The focus in this review of long-term effects on forest ecosystems is on human impact. As a classification of this differentiated and complex matter, three domains of long-term effects with different scales in space and time are distinguished: 1- Exploitation and conversion history of forests in areas of extended human settlement 2- Long-range air pollution and acid deposition in industrialized regions 3- Current global loss of forests and soil degradation.There is an evident link between the first and the third point in the list. Cultivation of primary forestland — with its tremendous effects on land cover — took place in Europe many centuries ago and continued for centuries. Deforestation today is a phenomenon predominantly observed in the developing countries, yet it threatens biotic and soil resources on a global scale. Acidification of forest soils caused by long-range air pollution from anthropogenic emission sources is a regional to continental problem in industrialized parts of the world. As a result of emission reduction legislation, atmospheric acid deposition is currently on the retreat in the richer industrialized regions (e.g., Europe, U.S., Japan); however, because many other regions of the world are at present rapidly developing their polluting industries (e.g., China and India), “acid rain” will most probably remain a serious ecological problem on regional scales. It is believed to have caused considerable destabilization of forest ecosystems, adding to the strong structural and biogeochemical impacts resulting from exploitation history.Deforestation and soil degradation cause the most pressing ecological problems for the time being, at least on the global scale. In many of those regions where loss of forests and soils is now high, it may be extremely difficult or impossible to restore forest ecosystems and soil productivity. Moreover, the driving forces, which are predominantly of a demographic and socioeconomic nature, do not yet seem to be lessening in strength. It can only be hoped that a wise policy of international cooperation and shared aims can cope with this problem in the future.

Download Full-text

365Disease burden of mumps in Japan: descriptive epidemiology based on the health insurance reimbursement database

International Journal of Epidemiology ◽

10.1093/ije/dyab168.505 ◽

2021 ◽

Vol 50 (Supplement_1) ◽

Author(s):

Satoko Ohfuji ◽

Akira Takagi ◽

Takashi Nakano ◽

Hideaki Kumihashi ◽

Munehide Kano ◽

...

Keyword(s):

Health Insurance ◽

Vaccination Coverage ◽

Disease Burden ◽

Descriptive Epidemiology ◽

Immunization Program ◽

Health Insurance Reimbursement ◽

Insurance Reimbursement ◽

National Immunization ◽

Icd 10 ◽

Reimbursement Database

Abstract Background In Japan, mumps vaccination coverage is low, since it is a voluntary vaccination. In this situation, the number of mumps cases as reported by pediatric sentinel hospitals suggests the occurrence of periodical mumps outbreaks. Methods To examine the annual incidences of mumps and mumps-related complications, we analyzed data from the health insurance reimbursement database for subscribers aged 0-64 years between 2005 and 2017. Cases with mumps and mumps-related complications including meningitis, orchitis, deafness, were extracted according to ICD-10 codes entered into the disease section for health insurance reimbursement. Results During the 13 year period, 68,307 of 5,209,660 subjects were reimbursed for mumps, with an incidence of 325 per 100,000 person-years (95% confidence interval (CI): 323-328). Among the 68,307 mumps cases, 787 were reimbursed for mumps-related complications, with an incidence of 11.5 per 1,000 mumps cases (95% CI: 10.7-12.4). Incidence of mumps-related complications (per 1,000 mumps cases) was highest for orchitis (6.6), followed by meningitis (5.8), deafness (1.3), pancreatitis (0.5), and encephalitis (0.3). Mumps incidence was highest among children aged 0-5 years, while incidence of mumps-related complications was highest among adults aged 26-35 years. Conclusions In Japan, the disease burden of mumps remains high among adults, as well as children. Key messages To reduce the disease burden of mumps among all ages in Japan, immunization in childhood is required. A national immunization program for children would result in high vaccination coverage and lower disease burden.

Download Full-text